These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21700407)

  • 1. [Hepatitis B reactivation with rituximab in an HIV-infected anti-HBs antibody carrier].
    Benghalia K; Roussin-Bretagne S; Marque-Juillet S; Colardelle P; Chochon M; Harzic M; Doll J
    Med Mal Infect; 2011 Aug; 41(8):437-9. PubMed ID: 21700407
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis.
    Zhang B; Wang J; Xu W; Wang L; Ni W
    Onkologie; 2010; 33(10):537-9. PubMed ID: 20926902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
    Cho CH; Hwang WL; Cheng SB; Lee TY; Teng CL
    Ann Hematol; 2011 Jan; 90(1):111-2. PubMed ID: 20407894
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
    Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N
    J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus reactivation in a primary central nervous system lymphoma patient following intrathecal rituximab treatment.
    Kim MG; Park SY; Kim EJ; Kim YM; Kim HY; Lee YK; Zang DY; Kim HJ
    Acta Haematol; 2011; 125(3):121-4. PubMed ID: 21150178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy.
    Kusumoto S; Tanaka Y; Mizokami M; Ueda R
    Hepatology; 2014 Aug; 60(2):765-6. PubMed ID: 24347499
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
    Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.
    Zachou K; Dalekos GN
    Liver Int; 2011 Mar; 31(3):277-9. PubMed ID: 21281426
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient.
    Montiel PM; Solis JA; Chirinos JA; a Casis B; Sánchez F; Rodríguez S
    Liver Int; 2008 May; 28(5):718-20. PubMed ID: 18433400
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V
    J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B reactivation and rituximab in the oncology practice.
    Villadolid J; Laplant KD; Markham MJ; Nelson DR; George TJ
    Oncologist; 2010; 15(10):1113-21. PubMed ID: 20930099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Boczanowski M; Gerwin R; Corcoran CP; Szczepiorkowski Z; Toner S; Cohen DE; Sax PE; Ukomadu C
    Clin Infect Dis; 2003 Jun; 36(12):1602-5. PubMed ID: 12802762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
    Matsue K; Kimura S; Takanashi Y; Iwama K; Fujiwara H; Yamakura M; Takeuchi M
    Cancer; 2010 Oct; 116(20):4769-76. PubMed ID: 20597091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.